← back to search

Jie Zheng

Qingdao University ·
Area of research
Immunology · Pathology and Forensic Medicine
Research interest
Research interests include Psoriasis: Treatment and Pathogenesis, Autoimmune Bullous Skin Diseases, Dermatology and Skin Diseases, and Inflammatory Myopathies and Dermatomyositis.
h-index
32
citations
5,422
works
235
NIH funding
primary concept
email

Recent publications

Gut microbiota in treating inflammatory digestive diseases: Current challenges and therapeutic opportunities
iMeta 2024cited by 15position: middledoi
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years
RMD Open 2022cited by 17position: middledoi
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses
Modern Rheumatology 2022cited by 6position: firstdoi
A Critical Role of the IL-1β–IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis
Journal of Investigative Dermatology 2018cited by 290position: middledoi
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
Annals of the Rheumatic Diseases 2018cited by 288position: middledoi
Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease
Nature Genetics 2016cited by 227position: middledoi
Exploration of candidate biomarkers for human psoriasis based on gas chromatography-mass spectrometry serum metabolomics
British Journal of Dermatology 2016cited by 113position: middledoi
Efficacy and safety of adalimumab in Chinese patients with moderate‐to‐severe plaque psoriasis: results from a phase 3, randomized, placebo‐controlled, double‐blind study
Journal of the European Academy of Dermatology and Venereology 2016cited by 99position: middledoi
Recurrent gain-of-function USP8 mutations in Cushing's disease
Cell Research 2015cited by 356position: middledoi
Ecto-5′-nucleotidase (CD73) is involved in chronic cerebral hypoperfusion-induced white matter lesions and cognitive impairment by regulating glial cell activation and pro-inflammatory cytokines
Neuroscience 2015cited by 37position: lastdoi

Grants

Mechanistic Design and Understanding of Fully Polymeric Antifreezing and Tough Hydrogels
NSF2603321$352,8922025–2026PIRePORTER
Rational Design and Fundamental Understanding of Multimodal Amyloid Probes
NSF2603320$153,7592025–2026PIRePORTER
Mechanistic Design and Understanding of Fully Polymeric Antifreezing and Tough Hydrogels
NSF2311985$418,0212023–2025PIRePORTER
Rational Design and Fundamental Understanding of Multimodal Amyloid Probes
NSF2107619$361,9962021–2026PIRePORTER
MRI: Acquisition of A High-sensitivity Electrospray Ionization Mass Spectrometer for Research and Education at the University of Texas at Dallas
NSF2018188$243,0872020–2023PIRePORTER
Combinatorial Design and Structure-Property Relationships of Antifouling Materials
NSF1806138$340,8662018–2023PIRePORTER
Design of Force-Sensitive Hydrogels for Adhesives and Strain Sensors
NSF1825122$302,0782018–2022PIRePORTER
Molecular Understanding and Design of Physically-linked Double Network Hydrogels
NSF1607475$343,6162016–2020PIRePORTER
UNS: Design of Self-Assembling Peptides and their Conjugates as Amyloid Inhibitors
NSF1510099$315,1242015–2019PIRePORTER
Molecular Design and Structural Basis of Peptide Inhibitors against Amyloid-beta Aggregation
NSF1158447$307,2812012–2015PIRePORTER
CAREER: Computational studies of the structure and biological activity of amyloid forming peptides
NSF0952624$422,4602010–2016PIRePORTER

Frequent collaborators

Fengchun Zhang · Ministry of Education of the People's Republic of China3 papers (2018–2022)David A. Roth · GlaxoSmithKline (United States)3 papers (2018–2022) · 3 papers (2018–2022)Yin Su · BGI Group (China)2 papers (2022–2022)Xingfu Li · Guangzhou University of Chinese Medicine2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2018–2022) · 2 papers (2022–2022) · 2 papers (2022–2022)Jieruo Gu · Sun Yat-sen University2 papers (2022–2022)Fei Hao · Nanjing Agricultural University1 papers (2016–2016) · 1 papers (2016–2016)Yihua Cai · University of Louisville1 papers (2018–2018)Jie Gu · Dalian Medical University1 papers (2016–2016)Minye Qu · University of Louisville1 papers (2018–2018)Chris Fleming · University of Louisville1 papers (2018–2018) · 1 papers (2016–2016)Chen Quan · China Pharmaceutical University1 papers (2018–2018)Ralph Weichselbaum · Tianjin University of Science and Technology1 papers (2018–2018)